Gene Delivery Using Viral Vectors - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 269

[222] Li YC, Kong LH, Cheng BZ, Li KS. Construction of influenza virus siRNA expres-
sion vectors and their inhibitory effects on multiplication of influenza virus. Avian Dis
2005;49:562-73.
[223] Zheng H, García-Sastre A. Potential applications of influenza A virus vectors as tumor
vaccines. Int Congr Ser 2001;1219:1029-35.
[224] Lamb RA, Choppin PW. The gene structure and replication of influenza virus. Annu
Rev Biochem 1983;52:467-506.
[225] Bouvier NM, Palese P. The biology of influenza viruses. Vaccine 2008;26:D49-53.
[226] Calos MP, Sclimenti CR. Assaying extrachromosomal gene therapy vectors that carry
replication/persistence elements. Adv Drug Deliv Rev 1998;30:13-21.
[227] Wang-Schick R, Jehan L, Jong Keun J, Woo Young C, Gye Soon Y. Hepatitis B virus
vectors for gene therapy. United States Patent 7001760.
[228] Nayak S, Herzog RW. Progress and prospects: immune responses to viral vectors. Gene
Ther 2010;17:295-304.
[229] Räty JK, Liimatainen T, Huhtala T, Kaikkonen MU, Airenne KJ, Hakumäki JM, et al.
SPECT/CT imaging of baculovirus biodistribution in rat. Gene Ther 2007;14:930-8.
[230] Räty JK, Liimatainen T, Wirth T, Airenne KJ, Ihalainen TO, Huhtala T, et al. Magnetic
resonance imaging of viral particle biodistribution in vivo . Gene Ther 2006;13:1440-6.